Literature DB >> 11809770

Insertional mutagenesis and immunochemical analysis of visual arrestin interaction with rhodopsin.

Astra Dinculescu1, J Hugh McDowell, Stephanie A Amici, Donald R Dugger, Nigel Richards, Paul A Hargrave, W Clay Smith.   

Abstract

Visual arrestin inactivates the phototransduction cascade by specifically binding to light-activated phosphorylated rhodopsin. This study describes the combined use of insertional mutagenesis and immunochemical approaches to probe the structural determinants of arrestin function. Recombinant arrestins with insertions of a 10-amino acid c-Myc tag (EQKLISEEDL) were expressed in yeast and characterized. When the tag was placed on the C terminus after amino acid 399, between amino acids 99 and 100 or between residues 162 and 163, binding to rhodopsin was found to be very similar to that of wild-type arrestin. Two stable mutants with Myc insertions in the 68-78 loop were also generated. Binding to rhodopsin was markedly decreased for one (72myc73) and completely abolished for the other (77myc78). Limited proteolysis assays using trypsin in the absence or presence of heparin were performed on all mutants and confirmed their overall conformational integrity. Rhodopsin binding to either 162myc163 or 72myc73 arrestins in solution was completely inhibited in the presence of less than a 2-fold molar excess of anti-Myc antibody relative to arrestin. In contrast, the antibody did not block the interaction of the 399myc or 99myc100 arrestins with rhodopsin. These results indicate that an interactive surface for rhodopsin is located on or near the concave region of the N-domain of arrestin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809770     DOI: 10.1074/jbc.M111833200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The differential engagement of arrestin surface charges by the various functional forms of the receptor.

Authors:  Susan M Hanson; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

2.  Arrestin translocation in rod photoreceptors.

Authors:  W Clay Smith; James J Peterson; Wilda Orisme; Astra Dinculescu
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

4.  Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Elena A Kolobova; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

5.  Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins.

Authors:  Sergey A Vishnivetskiy; Luis E Gimenez; Derek J Francis; Susan M Hanson; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

Review 6.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

7.  The role of arrestin alpha-helix I in receptor binding.

Authors:  Sergey A Vishnivetskiy; Derek Francis; Ned Van Eps; Miyeon Kim; Susan M Hanson; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2009-10-31       Impact factor: 5.469

8.  Enhanced phosphorylation-independent arrestins and gene therapy.

Authors:  Vsevolod V Gurevich; Xiufeng Song; Sergey A Vishnivetskiy; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Targeting individual GPCRs with redesigned nonvisual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Therapeutic potential of small molecules and engineered proteins.

Authors:  Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.